The Kentucky Viral Hepatitis Treatment Study

Completed · Phase 4

Conditions studied: Hepatitis C, Opioid-Related Disorders, Injection Drug Use

In brief

The overarching goal of the Kentucky Viral Hepatitis Treatment Project (KeY Treat) is to increase hepatitis C virus (HCV) treatment access and delivery in a rural Appalachian community, which is in the midst of the opioid/hepatitis C (HCV) syndemic. KeY Treat is a clinical research study seeking to determine whether removing barriers (cost, insurance, specialist, abstinence) associated with accessing direct-acting antivirals (DAAs) for the treatment of HCV will impact health in Perry County, Kentucky.

Key facts

Study ID

NCT03949764

Run by

Jennifer Havens

People needed

374

Starts

2019-09-23

Expected to finish

2025-06-30

Last updated by the study team

2025-08-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• RNA positive for HCV
• Perry County residency (verified via ID card showing local address, lease, utility bill, etc.)
• 18 years of age or older

You may not qualify if…

• Individuals who are unable to provide consent (to be determined by local study staff in conjunction with our psychiatrist, Dr. Lofwall, a Co-I on the study)
• Individuals under 18 years of age (study drugs not FDA-approved for those <18)
• Pregnant women (unable to participate during duration of pregnancy, but encouraged to return following delivery)

Where it is running

• ARH Medical Mall — Hazard, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.